Expression and clinical significance of β-catenin in multiple myeloma.

被引：0
|
作者：
Li, Juan [1 ]
Zhang, Dian-Bao [1 ]
Luo, Shao-kai [1 ]
Zhao, Ying [1 ]
Huang, Bei-Hui [1 ]
Gu, Jing-Li [1 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hematol, Guangzhou, Guangdong, Peoples R China
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5010
引用
收藏
页码：341B / 341B
页数：1
相关论文
共 50 条
  • [31] Clinical synergism of Bortezomib and chemotherapy in relapsed and refractory multiple myeloma.
    Mazumder, A
    Chauvin, E
    Curran, K
    Disperati, P
    Jagannath, S
    BLOOD, 2003, 102 (11) : 390B - 390B
  • [32] Molecular analysis in the clinical follow up of patients with multiple myeloma.
    Marinelli, G
    Terragna, C
    Cavo, K
    Lemoli, RM
    Bandini, G
    Zamagni, E
    Ronconi, S
    Tosi, P
    Mangianti, S
    Motta, MR
    Zagarella, MS
    Testoni, N
    Amabile, M
    Ottaviani, E
    Tura, S
    BLOOD, 1999, 94 (10) : 384B - 384B
  • [33] Clinical grade SNaPshot genetic mutation profiling in multiple myeloma.
    O'Donnell, Elizabeth
    Mahindra, Anuj Kumar
    Yee, Andrew Jenho
    Birrer, Nicole
    Horick, Nora
    Finkelstein, Dianne M.
    Borger, Darrell R.
    Iafrato, A. John
    Raje, Noopur S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [34] Clinical characteristics of young (age ≤50) patients with multiple myeloma.
    Niesvizky, R
    Lyons, L
    Michaeli, J
    BLOOD, 2000, 96 (11) : 279B - 279B
  • [35] Plasma concentration of thalidomide and clinical efficacy in patients with multiple myeloma.
    Hattori, Y
    Kakimoto, T
    Okamoto, S
    Iguchi, T
    Morita, K
    Tanigawara, Y
    Ikeda, Y
    BLOOD, 2003, 102 (11) : 689A - 689A
  • [36] Demographic disparities in genomic data and clinical trials for multiple myeloma.
    Aggarwal, Nidhi
    Ahluwalia, Pankaj Kumar
    Kolhe, Ravindra B.
    Cortes, Jorge E.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [37] Differential expression of telomerase activity in plasma cells from patients with monoclonal gammopathy of undetermined significance and multiple myeloma.
    Cheryk, LA
    Katzmann, JA
    Ahmann, GJ
    Greipp, PR
    O'Kane, DJ
    CLINICAL CHEMISTRY, 1999, 45 (06) : A108 - A108
  • [38] Multiple myeloma. Epidemiology and staging
    Hillengass, J.
    Goldschmidt, H.
    ONKOLOGE, 2010, 16 (03): : 225 - +
  • [39] Multiple myeloma. Imaging diagnostics
    Baur-Melnyk, A.
    Reiser, M. F.
    ONKOLOGE, 2010, 16 (03): : 242 - +
  • [40] Newly diagnosed multiple myeloma.
    Weber D.M.
    Current Treatment Options in Oncology, 2002, 3 (3) : 235 - 245
12345